CELZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Creative Medical Technology Holdings Inc (CELZ) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical analysis shows mixed signals with bearish moving averages, and there are no significant positive catalysts such as news, trading trends, or recent congress trading data. Additionally, the company's financial performance shows weak growth trends, including negative net income and declining EPS. Given the lack of strong buy signals and the potential for a short-term price decline, it is better to hold off on investing in CELZ at this time.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral at 70.322, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near resistance levels (R1: 1.984, R2: 2.041), suggesting limited upside potential in the short term. Historical patterns indicate a 70% chance of a price decline in the next day (-0.29%), week (-0.5%), and month (-7.36%).
NULL. There is no recent news, significant trading trends, or congress trading data to act as positive catalysts.
The stock is showing a bearish trend in moving averages, and historical patterns suggest a high probability of short-term price declines. Additionally, the company's financial performance remains weak, with negative net income and declining EPS.
In Q4 2025, revenue remained flat YoY at 3000. Net income improved slightly but remains negative at -1,887,674 (up 1.81% YoY). EPS dropped significantly by -35.78% YoY to -0.7, and gross margin improved but is still negative at -964.77 (up 38.89% YoY). Overall, the financials indicate weak growth and profitability trends.
No analyst rating or price target changes available.
